Center-Authored Papers

Filters: Author is Tan, Xiaoxia  [Clear All Filters]
Journal Article
Stromnes IM, Blattman JN, Tan X, Jeevanjee S, Gu H, Greenberg PD.  2010.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.. The Journal of clinical investigation. 120(10):3722-34. Abstract
Stromnes IM, Fowler C, Casamina CC, Georgopolos CM, McAfee MS, Schmitt TM, Tan X, Kim T-D, Choi I, Blattman JN et al..  2012.  Abrogation of SRC homology region 2 domain-containing phosphatase 1 in tumor-specific T cells improves efficacy of adoptive immunotherapy by enhancing the effector function and accumulation of short-lived effector T cells in vivo.. Journal of immunology (Baltimore, Md. : 1950). 189(4):1812-25. Abstract
Dossett ML, Teague RM, Schmitt TM, Tan X, Cooper LJ, Pinzon C, Greenberg PD.  2009.  Adoptive immunotherapy of disseminated leukemia with TCR-transduced, CD8+ T cells expressing a known endogenous TCR.. Molecular therapy : the journal of the American Society of Gene Therapy. 17(4):742-9. Abstract
Oda SK, Daman AW, Garcia NM, Wagener F, Schmitt TM, Tan X, Chapuis AG, Greenberg PD.  2017.  A CD200R-CD28 fusion protein appropriates an inhibitory signal to enhance T cell function and therapy of murine leukemia.. Blood. 130(22):2410-2419. Abstract
Chou CK, Schietinger A, Liggitt DH, Tan X, Funk S, Freeman GJ, Ratliff TL, Greenberg NM, Greenberg PD.  2012.  Cell-Intrinsic Abrogation of TGF-β Signaling Delays but Does Not Prevent Dysfunction of Self/Tumor-Specific CD8 T Cells in a Murine Model of Autochthonous Prostate Cancer.. Journal of immunology (Baltimore, Md. : 1950). 189(8):3936-46. Abstract
Kim T-D, Jung H-R, Seo S-H, Oh S-C, Ban Y, Tan X, Kim J, Lee S, Koh D-S, Jung H et al..  2017.  MicroRNA-150 modulates intracellular Ca (2+) levels in naïve CD8(+) T cells by targeting TMEM20.. Scientific reports. 7(1):2623. Abstract
Teague RM, Greenberg PD, Fowler C, Huang MZ, Tan X, Morimoto J, Dossett ML, Huseby ES, Ohlén C.  2008.  Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor.. Immunity. 28(5):662-74. Abstract
Stromnes IM, Schmitt TM, Hulbert A, Brockenbrough SJ, Nguyen HN, Cuevas C, Dotson AM, Tan X, Hotes JL, Greenberg PD et al..  2015.  T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma.. Cancer cell. 28(5):638-52. Abstract